ADBE:NASDAQAdobe Inc. Analysis
Data as of 2026-05-14 - not real-time
$236.07
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Adobe is trading well below its intrinsic valuation, with the market price roughly half of the discounted cash‑flow estimate and a forward P/E that undercuts the sector average by a wide margin. Strong cash generation supports an aggressive share‑repurchase program, which analysts view as a signal that the stock is undervalued despite recent price weakness. The company maintains high profitability metrics—gross margins near 90% and operating margins above 38%—and revenue is still expanding at double‑digit rates. However, technical indicators are currently bearish: the 20‑day SMA sits below the 50‑day SMA, the MACD is in a bearish crossover, and the RSI hovers in the lower‑mid range, all suggesting short‑term pressure. Recent news of a sizable buyback and notable investor interest, including backing from a high‑profile contrarian fund, adds a contrarian upside narrative.
Risk factors include elevated 30‑day volatility and a recent decline in trading volume, which could amplify price swings in a rising‑rate environment. Nonetheless, Adobe’s low beta, limited regulatory exposure, and dominant position in the creative‑software market mitigate broader sector and geographic risks. The balance of strong fundamentals, attractive valuation, and strategic AI initiatives positions Adobe as a compelling long‑term investment, while short‑term caution is warranted due to the current bearish technical setup.
Risk factors include elevated 30‑day volatility and a recent decline in trading volume, which could amplify price swings in a rising‑rate environment. Nonetheless, Adobe’s low beta, limited regulatory exposure, and dominant position in the creative‑software market mitigate broader sector and geographic risks. The balance of strong fundamentals, attractive valuation, and strategic AI initiatives positions Adobe as a compelling long‑term investment, while short‑term caution is warranted due to the current bearish technical setup.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD and SMA crossover
- Elevated short‑term volatility
- Recent price pullback after treasury‑yield moves
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant undervaluation versus DCF fair value
- Robust cash flow enabling share repurchases
- Forward earnings multiple well below industry peers
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Sustainable high margins and recurring SaaS revenue
- Strategic AI partnership expanding product capabilities
- Strong balance sheet with ample cash and manageable leverage
Key Metrics & Analysis
Financial Health
Revenue Growth12.00%
Profit Margin29.48%
P/E Ratio13.8
ROE58.77%
ROA18.91%
Debt/Equity58.34
P/B Ratio8.4
Op. Cash Flow$10.5B
Free Cash Flow$9.3B
Industry P/E38.8
Technical Analysis
TrendBearish
RSI41.6
Support$232.84
Resistance$259.44
MA 20$247.20
MA 50$248.93
MA 200$309.42
MACDBearish
VolumeDecreasing
Fear & Greed Index89.55
Valuation
Fair Value$505.05
Target Price$327.96
Upside/Downside38.92%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.66
Volatility41.71%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.